{"id":9125,"date":"2026-02-27T16:55:16","date_gmt":"2026-02-27T19:55:16","guid":{"rendered":"https:\/\/portal.pi.gov.br\/sesapi\/?p=9125"},"modified":"2026-02-27T16:55:17","modified_gmt":"2026-02-27T19:55:17","slug":"sesapi-orienta-municipios-sobre-vacinacao-contra-dengue-e-uso-do-nirsevimabe","status":"publish","type":"post","link":"https:\/\/portal.pi.gov.br\/sesapi\/2026\/02\/27\/sesapi-orienta-municipios-sobre-vacinacao-contra-dengue-e-uso-do-nirsevimabe\/","title":{"rendered":"Sesapi orienta munic\u00edpios sobre vacina\u00e7\u00e3o contra dengue e uso do nirsevimabe"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>A Secretaria de Estado da Sa\u00fade (Sesapi) realizou, nesta sexta-feira (27), uma reuni\u00e3o virtual com coordenadores municipais, profissionais da Aten\u00e7\u00e3o Prim\u00e1ria e vacinadores para atualizar orienta\u00e7\u00f5es sobre a vacina contra a dengue e o uso do nirsevimabe, anticorpo indicado para prevenir bronquiolite causada pelo v\u00edrus sincicial respirat\u00f3rio (VSR).<\/p>\n\n\n\n<p>Durante o encontro, foram apresentadas as estrat\u00e9gias de aplica\u00e7\u00e3o e seguran\u00e7a dos imunizantes para profissionais de sa\u00fade e p\u00fablico definidos. A vacina da Takeda \u00e9 destinada a pessoas de 10 a 14 anos, em duas doses com intervalo de tr\u00eas meses. J\u00e1 o imunizante do Instituto Butantan \u00e9 indicado para pessoas de 15 a 59 anos, em dose \u00fanica. A meta \u00e9 atingir 90% de cobertura vacinal nos p\u00fablicos definidos.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"437\" src=\"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-1024x437.jpg\" alt=\"\" class=\"wp-image-9127\" srcset=\"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-1024x437.jpg 1024w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-300x128.jpg 300w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-768x328.jpg 768w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-420x179.jpg 420w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-540x230.jpg 540w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-780x333.jpg 780w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-947x404.jpg 947w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451-624x266.jpg 624w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/syur451.jpg 1303w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>A Sesapi refor\u00e7ou que a vacina\u00e7\u00e3o deve ocorrer exclusivamente em unidades de sa\u00fade e que o esquema iniciado deve ser conclu\u00eddo com o mesmo imunizante. Tamb\u00e9m foram destacadas orienta\u00e7\u00f5es sobre monitoramento e notifica\u00e7\u00e3o de eventos adversos, como anafilaxia, trombose e s\u00edndrome de Guillain-Barr\u00e9, por meio do sistema e-SUS Notifica, conforme diretrizes do Minist\u00e9rio da Sa\u00fade e da Anvisa.<\/p>\n\n\n\n<p>Al\u00e9m disso, foram alertados os principais erros de imuniza\u00e7\u00e3o que devem ser evitados e notificados, como aplica\u00e7\u00e3o fora da faixa et\u00e1ria recomendada ou em gestantes, que devem ser acompanhadas pela vigil\u00e2ncia epidemiol\u00f3gica.<\/p>\n\n\n\n<p>A coordenadora estadual de imuniza\u00e7\u00e3o, B\u00e1rbara Pinheiro, destacou a import\u00e2ncia da qualifica\u00e7\u00e3o das equipes. \u201cNosso objetivo \u00e9 garantir seguran\u00e7a na aplica\u00e7\u00e3o, ampliar a cobertura vacinal e fortalecer a confian\u00e7a da popula\u00e7\u00e3o\u201d, afirmou.<\/p>\n\n\n\n<p>A iniciativa integra as a\u00e7\u00f5es da Sesapi para enfrentamento da dengue e fortalecimento da imuniza\u00e7\u00e3o em todo o estado.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" loading=\"lazy\" width=\"959\" height=\"533\" src=\"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg\" alt=\"\" class=\"wp-image-9126\" srcset=\"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg 959w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-300x167.jpg 300w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-768x427.jpg 768w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-420x233.jpg 420w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-540x300.jpg 540w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-780x434.jpg 780w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-947x526.jpg 947w, https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-624x347.jpg 624w\" sizes=\"(max-width: 959px) 100vw, 959px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>A Secretaria de Estado da Sa\u00fade (Sesapi) realizou, nesta sexta-feira (27), uma reuni\u00e3o virtual com coordenadores municipais, profissionais da Aten\u00e7\u00e3o Prim\u00e1ria e vacinadores para atualizar orienta\u00e7\u00f5es sobre a vacina contra [&hellip;]<\/p>\n","protected":false},"author":1814,"featured_media":9126,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[30],"tags":[66,73,52,142,43,36],"featured_image_urls":{"full":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"thumbnail":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-150x150.jpg",150,150,true],"medium":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-300x167.jpg",300,167,true],"medium_large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-768x427.jpg",768,427,true],"large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",887,493,false],"sgg-420":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-420x233.jpg",420,233,true],"sgg-540":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-540x300.jpg",540,300,true],"sgg-780":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-780x434.jpg",780,434,true],"1536x1536":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"2048x2048":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"homepage-slider":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-959x500.jpg",959,500,true],"homepage-slider-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-947x500.jpg",947,500,true],"page-top":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-947x526.jpg",947,526,true],"page-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-624x347.jpg",624,347,true],"loop-main":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-365x240.jpg",365,240,true],"thumb-gallery-widget":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-84x56.jpg",84,56,true]},"post_excerpt_stackable":"<p>A Secretaria de Estado da Sa\u00fade (Sesapi) realizou, nesta sexta-feira (27), uma reuni\u00e3o virtual com coordenadores municipais, profissionais da Aten\u00e7\u00e3o Prim\u00e1ria e vacinadores para atualizar orienta\u00e7\u00f5es sobre a vacina contra a dengue e o uso do nirsevimabe, anticorpo indicado para prevenir bronquiolite causada pelo v\u00edrus sincicial respirat\u00f3rio (VSR). Durante o encontro, foram apresentadas as estrat\u00e9gias de aplica\u00e7\u00e3o e seguran\u00e7a dos imunizantes para profissionais de sa\u00fade e p\u00fablico definidos. A vacina da Takeda \u00e9 destinada a pessoas de 10 a 14 anos, em duas doses com intervalo de tr\u00eas meses. J\u00e1 o imunizante do Instituto Butantan \u00e9 indicado para pessoas de&hellip;<\/p>\n","category_list":"<a href=\"https:\/\/portal.pi.gov.br\/sesapi\/category\/noticias\/\" rel=\"category tag\">Not\u00edcias<\/a>","author_info":{"name":"elisangelapegado","url":"https:\/\/portal.pi.gov.br\/sesapi\/author\/elisangelapegado\/"},"comments_num":"0 coment\u00e1rio","featured_image_urls_v2":{"full":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"thumbnail":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-150x150.jpg",150,150,true],"medium":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-300x167.jpg",300,167,true],"medium_large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-768x427.jpg",768,427,true],"large":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",887,493,false],"sgg-420":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-420x233.jpg",420,233,true],"sgg-540":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-540x300.jpg",540,300,true],"sgg-780":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-780x434.jpg",780,434,true],"1536x1536":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"2048x2048":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg",959,533,false],"homepage-slider":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-959x500.jpg",959,500,true],"homepage-slider-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-947x500.jpg",947,500,true],"page-top":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-947x526.jpg",947,526,true],"page-small":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-624x347.jpg",624,347,true],"loop-main":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-365x240.jpg",365,240,true],"thumb-gallery-widget":["https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9-84x56.jpg",84,56,true]},"post_excerpt_stackable_v2":"<p>A Secretaria de Estado da Sa\u00fade (Sesapi) realizou, nesta sexta-feira (27), uma reuni\u00e3o virtual com coordenadores municipais, profissionais da Aten\u00e7\u00e3o Prim\u00e1ria e vacinadores para atualizar orienta\u00e7\u00f5es sobre a vacina contra a dengue e o uso do nirsevimabe, anticorpo indicado para prevenir bronquiolite causada pelo v\u00edrus sincicial respirat\u00f3rio (VSR). Durante o encontro, foram apresentadas as estrat\u00e9gias de aplica\u00e7\u00e3o e seguran\u00e7a dos imunizantes para profissionais de sa\u00fade e p\u00fablico definidos. A vacina da Takeda \u00e9 destinada a pessoas de 10 a 14 anos, em duas doses com intervalo de tr\u00eas meses. J\u00e1 o imunizante do Instituto Butantan \u00e9 indicado para pessoas de&hellip;<\/p>\n","category_list_v2":"<a href=\"https:\/\/portal.pi.gov.br\/sesapi\/category\/noticias\/\" rel=\"category tag\">Not\u00edcias<\/a>","author_info_v2":{"name":"elisangelapegado","url":"https:\/\/portal.pi.gov.br\/sesapi\/author\/elisangelapegado\/"},"comments_num_v2":"0 coment\u00e1rio","jetpack_featured_media_url":"https:\/\/portal.pi.gov.br\/sesapi\/wp-content\/uploads\/sites\/101\/2026\/02\/clr9.jpg","_links":{"self":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/9125"}],"collection":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/users\/1814"}],"replies":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/comments?post=9125"}],"version-history":[{"count":1,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/9125\/revisions"}],"predecessor-version":[{"id":9128,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/posts\/9125\/revisions\/9128"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/media\/9126"}],"wp:attachment":[{"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/media?parent=9125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/categories?post=9125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portal.pi.gov.br\/sesapi\/wp-json\/wp\/v2\/tags?post=9125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}